| 2026-08-17 | Press release | OmniAb Raises 2026 Financial Guidance |
| 2026-08-17 | Press release | OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company |
| 2026-08-06 | Press release | OmniAb to Report Second Quarter 2026 Financial Results on August 6 |
| 2026-08-06 | Press release | Press Release |
| 2026-07-13 | Press release | OmniAb Names Amechi Nwachuku Chief Operating Officer |
| 2026-05-07 | Press release | Press Release |
| 2026-05-07 | Press release | OmniAb to Report First Quarter 2026 Financial Results on May 7 |
| 2026-05-07 | Earnings deck | Presentation
of Q1 2026, PDF file, (opens in new window) |
| 2026-03-08 | Press release | OmniAb to Participate at the Leerink Partners Global Healthcare Conference |
| 2026-03-04 | Press release | Press Release |
| 2026-03-04 | Press release | OmniAb to Report Fourth Quarter 2025 Financial Results on March 4 |
| 2025-12-15 | Press release | Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery |
| 2025-12-15 | Press release | OmniAb to Hold OmniUltra Virtual Investor Event on December 15 |
| 2025-11-19 | Presentation | Presentation |
| 2025-11-17 | Press release | OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Comp |
| 2025-11-03 | Quarterly report | Q3 2025 Financial Results & Business Update call |
| 2025-11-04 | Press release | OmniAb to Report Third Quarter 2025 Financial Results on November 4 |
| 2025-10-16 | Press release | OmniAb to Participate in Three Investor Conferences in November |
| 2025-08-25 | Press release | OmniAb Announces $30 Million Private Placement |
| 2025-08-05 | Quarterly report | Q2 2025 Financial Results & Business Update call |
| 2025-08-06 | Quarterly report | Quarterly Filing |
| 2025-08-06 | Press release | OmniAb to Report Second Quarter 2025 Financial Results on August 6 |
| 2025-05-13 | Press release | OmniAb Showcases Innovative High-Throughput Single B-cell Screening xPloration® Platform at the 21st Annual PEGS Boston |
| 2025-05-08 | Quarterly report | Q1 2025 Financial Results & Business Update earnings call |
| 2025-05-08 | Press release | OmniAb to Report First Quarter 2025 Financial Results on May 8 |
| 2025-05-08 | Press release | OmniAb Introduces the xPloration® Partner Access Program |
| 2025-05-01 | Press release | OmniAb to Participate in Five Upcoming Investor Conferences |
| 2025-04-21 | Press release | OmniAb Announces Two New Appointments to its Board of Directors |
| 2025-03-18 | Quarterly report | Q4 2024 Financial Results & Business Update earnings call |
| 2025-03-18 | Press release | OmniAb to Report Fourth Quarter 2024 Financial Results on March 18 |
| 2025-02-03 | Press release | OmniAb to Participate in Two Investor Conferences in March |
| 2024-12-16 | Press release | OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference |
| 2024-11-12 | Press release | OmniAb to Report Third Quarter 2024 Financial Results on November 12 |
| 2024-11-12 | Press release | OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights |
| 2024-11-12 | Press release | Press Release |
| 2024-10-30 | Press release | OmniAb to Participate in Two Investor Conferences in November |
| 2024-08-26 | Press release | OmniAb to Participate in Two Investor Conferences in September |
| 2024-08-08 | Press release | OmniAb to Report Second Quarter 2024 Financial Results on August 8 |
| 2024-08-08 | Presentation | Presentation |
| 2024-08-08 | Press release | Press Release |